NeuroSense Therapeutics Ltd.
NRSNW·NasdaqCM
0.0129+0.0054 (+72.00%)today
At close: Nov 4, 3:55 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0075
Open0.3000
Day range0.00990.0130
52-week range0.00990.0130
Off day high−0.77%
Off 52-week high−0.77%
Volume2.75K
Avg. volume (3M)—
Market cap—
EPS (TTM)-0.9350
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.72
Shares outstanding—
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| NRSNW | PRAX | B9A.F | JUNS | PTCT | PRTA | |
|---|---|---|---|---|---|---|
| Market cap | — | 7.95B | 2.45B | 3.24M | 5.76B | 430.72M |
| P/E (TTM) | — | — | 250.7 | — | — | — |
| Forward P/E | — | -30.0 | — | 41.0 | 28.4 | -6.4 |
| Price/book | 0.0 | 5.9 | 1.2 | -4.5 | -30.1 | 1.5 |
| Dividend yield | — | — | 0.68% | — | — | — |
| 1-year change | — | +65.24% | +13.08% | −97.59% | −4.99% | −16.77% |
| Today | +72.00% | +1.53% | −0.29% | +1.23% | +1.25% | +2.19% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All NRSNW news ›Neurosense Therapeutics Ltd. News — FWB:H1Z
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.